A guide to interpreting economic studies in infectious diseases.
Healthcare providers continue to seek improved methods for preventing, detecting and treating diseases that affect human survival and quality of life. At the same time, there will always be financial constraints because of limited societal resources. Many of the discussions on how to provide economically sound solutions to this challenge have not fully engaged the input of clinicians in the field. The purpose of this review is to increase economic knowledge for clinicians. We cover healthcare cost elements and methods used to assign value to a health outcome. We outline the challenges in conducting economic studies in the field of infectious diseases. Finally, we discuss the meaning of efficiency from multiple perspectives, and how the concept of economic externalities applies to infectious diseases.
Roberts
R R
RR
Department of Emergency Medicine, John H. Stroger Jr. Hospital of Cook County, 1900 West Polk Street, Chicago, IL 60612, USA. rroberts@ccbh.org
Mensah
E K
EK
Weinstein
R A
RA
D003141:Communicable Diseases / Q000191:economics*; D003362:Cost-Benefit Analysis; D004526:Efficiency; D004864:Equipment and Supplies / Q000191:economics; D017048:Health Care Costs; D006295:Health Resources / Q000191:economics*; D006801:Humans; D008494:Medical Office Buildings / Q000191:economics; D017063:Outcome Assessment, Health Care / Q000191:economics*; D010348:Patient Care Team / Q000191:economics; D011788:Quality of Life; D016896:Treatment Outcome